1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Post-COVID-19: new trials by email Literature Review of Post-COVID-19 trials Research Report on Post-COVID-19
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate the Safety and Efficacy of Meplazumab in Treatment of Post-COVID-19 Meplazumab for injection, Normal saline - Post-COVID-19 | Phase 3 | Completed | Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd | 121 | 2023-03-23 | 2024-05-28 |
Injections (1) · Saline Solution (1) · meplazumab (1)
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd (1)
China (1)